Dren Bio

Dren Bio is a privately held, biopharmaceutical company based in San Carlos, California, focused on developing therapeutic antibodies for the treatment of cancer, autoimmune, and other serious diseases. The company's management team and scientific advisors have significant expertise in the discovery and development of engineered antibodies designed to selectively target and deplete pathologic cells, protein aggregates, and other disease-causing agents.